Literature DB >> 30445441

Thyroid Cancer and Benign Nodules After Exposure In Utero to Fallout From Chernobyl.

Maureen Hatch1, Alina V Brenner1, Elizabeth K Cahoon1, Vladimir Drozdovitch1, Mark P Little1, Tatiana Bogdanova2, Victor Shpak2, Elena Bolshova2, Galyna Zamotayeva2, Galyna Terekhova2, Evgeniy Shelkovoy2, Viktoria Klochkova2, Kiyohiko Mabuchi1, Mykola Tronko2.   

Abstract

Background: Children and adolescents exposed to radioactive iodine-131 (I-131) in fallout from the 1986 Chernobyl nuclear accident appear to be at increased risk of thyroid cancer and benign thyroid nodules. The prenatal period is also considered radiosensitive, and the fetal thyroid can absorb I-131 from the maternal circulation.
Objectives: We aimed to estimate the risk of malignant and benign thyroid nodules in individuals exposed prenatally.
Methods: We studied a cohort of 2582 subjects in Ukraine with estimates of I-131 prenatal thyroid dose (mean = 72.6 mGy), who underwent two standardized thyroid screening examinations. To evaluate the dose-response relationship, we estimated the excess OR (EOR) using logistic regression.
Results: Based on a combined total of eight cases diagnosed at screenings from 2003 to 2006 and 2012 to 2015, we found a markedly elevated, albeit not statistically significant, dose-related risk of thyroid cancer (EOR/Gy = 3.91, 95% CI: -1.49, 65.66). At cycle 2 (n = 1,786), there was a strong and significant association between I-131 thyroid dose and screen-detected large benign nodules (≥10 mm) (EOR/Gy = 4.19, 95% CI: 0.68, 11.62; P = 0.009), but no significant increase in risk for small nodules (<10 mm) (EOR/Gy = 0.34, 95% CI: -0.67, 2.24; P = 0.604). Conclusions: The dose effect by nodule size, with I-131 risk for large but not small nodules, is similar to that among exposed children and adolescents in Belarus. Based on a small number of cases, there is also a suggestive effect of I-131 dose on thyroid cancer risk.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30445441      PMCID: PMC6456983          DOI: 10.1210/jc.2018-00847

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

1.  Dosimetry of radioiodine for embryo and fetus.

Authors:  V Berkovski; K F Eckerman; A W Phipps; D Nosske
Journal:  Radiat Prot Dosimetry       Date:  2003       Impact factor: 0.972

2.  RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.

Authors:  R Elisei; C Romei; T Vorontsova; B Cosci; V Veremeychik; E Kuchinskaya; F Basolo; E P Demidchik; P Miccoli; A Pinchera; F Pacini
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

Review 3.  Clinical practice. The thyroid nodule.

Authors:  Laszlo Hegedüs
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

4.  Thyroid neoplasia risk is increased nearly 30 years after the Chernobyl accident.

Authors:  Mykola Tronko; Alina V Brenner; Tetiana Bogdanova; Victor Shpak; Valeriy Oliynyk; Elizabeth K Cahoon; Vladimir Drozdovitch; Mark P Little; Valeriy Tereshchenko; Galyna Zamotayeva; Galyna Terekhova; Lyudmila Zurnadzhi; Maureen Hatch; Kiyohiko Mabuchi
Journal:  Int J Cancer       Date:  2017-07-10       Impact factor: 7.396

5.  Thyroid disease associated with exposure to the Nevada nuclear weapons test site radiation: a reevaluation based on corrected dosimetry and examination data.

Authors:  Joseph L Lyon; Stephen C Alder; Mary Bishop Stone; Alan Scholl; James C Reading; Richard Holubkov; Xiaoming Sheng; George L White; Kurt T Hegmann; Lynn Anspaugh; F Owen Hoffman; Steven L Simon; Brian Thomas; Raymond Carroll; A Wayne Meikle
Journal:  Epidemiology       Date:  2006-11       Impact factor: 4.822

6.  Risk of Thyroid Nodules in Residents of Belarus Exposed to Chernobyl Fallout as Children and Adolescents.

Authors:  Elizabeth K Cahoon; Eldar A Nadyrov; Olga N Polyanskaya; Vasilina V Yauseyenka; Ilya V Veyalkin; Tamara I Yeudachkova; Tamara I Maskvicheva; Victor F Minenko; Wayne Liu; Vladimir Drozdovitch; Kiyohiko Mabuchi; Mark P Little; Lydia B Zablotska; Robert J McConnell; Maureen Hatch; Kamau O Peters; Alexander V Rozhko; Alina V Brenner
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

Review 7.  Radioiodine and pregnancy.

Authors:  C A Gorman
Journal:  Thyroid       Date:  1999-07       Impact factor: 6.568

8.  Association of radiation dose with prevalence of thyroid nodules among atomic bomb survivors exposed in childhood (2007-2011).

Authors:  Misa Imaizumi; Waka Ohishi; Eiji Nakashima; Nobuko Sera; Kazuo Neriishi; Michiko Yamada; Yoshimi Tatsukawa; Ikuno Takahashi; Saeko Fujiwara; Keizo Sugino; Takao Ando; Toshiro Usa; Atsushi Kawakami; Masazumi Akahoshi; Ayumi Hida
Journal:  JAMA Intern Med       Date:  2015-02       Impact factor: 21.873

9.  A cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: dose-response analysis of thyroid follicular adenomas detected during first screening in Ukraine (1998-2000).

Authors:  Lydia B Zablotska; Tetyana I Bogdanova; Elaine Ron; Ovsiy V Epstein; Jacob Robbins; Illya A Likhtarev; Maureen Hatch; Valentyn V Markov; Andre C Bouville; Valery A Olijnyk; Robert J McConnell; Victor M Shpak; Alina Brenner; Galina N Terekhova; Ellen Greenebaum; Valery P Tereshchenko; Daniel J Fink; Aaron B Brill; Galina A Zamotayeva; Ihor J Masnyk; Geoffrey R Howe; Mykola D Tronko
Journal:  Am J Epidemiol       Date:  2007-11-06       Impact factor: 4.897

10.  Impact of Uncertainties in Exposure Assessment on Thyroid Cancer Risk among Persons in Belarus Exposed as Children or Adolescents Due to the Chernobyl Accident.

Authors:  Mark P Little; Deukwoo Kwon; Lydia B Zablotska; Alina V Brenner; Elizabeth K Cahoon; Alexander V Rozhko; Olga N Polyanskaya; Victor F Minenko; Ivan Golovanov; André Bouville; Vladimir Drozdovitch
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

View more
  12 in total

1.  Epidemiology of Thyroid Cancer.

Authors:  Cari M Kitahara; Arthur B Schneider
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-07-01       Impact factor: 4.090

2.  Assessment of internal exposure to 131I and short-lived radioiodine isotopes and associated uncertainties in the Ukrainian cohort of persons exposed in utero.

Authors:  Sergii Masiuk; Mykola Chepurny; Valentyna Buderatska; Olga Ivanova; Zulfira Boiko; Natalia Zhadan; Maureen Hatch; Elizabeth K Cahoon; Galyna Zamotayeva; Victor Shpak; Mykola Tronko; Vladimir Drozdovitch
Journal:  J Radiat Res       Date:  2022-05-18       Impact factor: 2.438

3.  THYROID SCREENING AND RELIABILITY OF RADIATION THYROID DOSES FOR THE BELARUSIAN IN UTERO COHORT.

Authors:  V Drozdovitch; V V Yauseyenka; V F Minenko; I V Veyalkin; T S Kukhta; R I Grakovitch; S Trofimik; O N Polyanskaya; L Starastsenka; E K Cahoon; M Hatch; M P Little; A V Brenner; E Ostroumova; K Mabuchi; A V Rozhko
Journal:  Probl Radiac Med Radiobiol       Date:  2021-12

4.  Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study.

Authors:  Cari M Kitahara; Dagrun Slettebø Daltveit; Anders Ekbom; Anders Engeland; Mika Gissler; Ingrid Glimelius; Tom Grotmol; Ylva Trolle Lagerros; Laura Madanat-Harjuoja; Tuija Männistö; Henrik Toft Sørensen; Rebecca Troisi; Tone Bjørge
Journal:  Lancet Diabetes Endocrinol       Date:  2020-12-18       Impact factor: 32.069

5.  Belarusian in utero cohort: A new opportunity to evaluate the health effects of prenatal and early-life exposure to ionising radiation.

Authors:  Vasilina Yauseyenka; Vladimir Drozdovitch; Evgenia Ostroumova; Olga Polyanskaya; Victor Minenko; Alina Brenner; Maureen Hatch; Mark P Little; Elizabeth K Cahoon; Tatiana Kukhta; Liliya Starastsenka; Rimma Grakovitch; Andrey Cheshik; Ilya Veyalkin; Alexander Rozhko; Kiyohiko Mabuchi
Journal:  J Radiol Prot       Date:  2019-11-26       Impact factor: 1.559

6.  Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident.

Authors:  Lindsay M Morton; Danielle M Karyadi; Chip Stewart; Tetiana I Bogdanova; Eric T Dawson; Mia K Steinberg; Jieqiong Dai; Stephen W Hartley; Sara J Schonfeld; Joshua N Sampson; Yosef E Maruvka; Vidushi Kapoor; Dale A Ramsden; Juan Carvajal-Garcia; Charles M Perou; Joel S Parker; Marko Krznaric; Meredith Yeager; Joseph F Boland; Amy Hutchinson; Belynda D Hicks; Casey L Dagnall; Julie M Gastier-Foster; Jay Bowen; Olivia Lee; Mitchell J Machiela; Elizabeth K Cahoon; Alina V Brenner; Kiyohiko Mabuchi; Vladimir Drozdovitch; Sergii Masiuk; Mykola Chepurny; Liudmyla Yu Zurnadzhy; Maureen Hatch; Amy Berrington de Gonzalez; Gerry A Thomas; Mykola D Tronko; Gad Getz; Stephen J Chanock
Journal:  Science       Date:  2021-04-22       Impact factor: 63.714

Review 7.  Radiation Exposure to the Thyroid After the Chernobyl Accident.

Authors:  Vladimir Drozdovitch
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-05       Impact factor: 5.555

8.  Birth Characteristics and Risk of Pediatric Thyroid Cancer: A Population-Based Record-Linkage Study in California.

Authors:  Nicole C Deziel; Yawei Zhang; Rong Wang; Joseph L Wiemels; Libby Morimoto; Cassandra J Clark; Catherine Metayer; Xiaomei Ma
Journal:  Thyroid       Date:  2020-10-07       Impact factor: 6.568

9.  Updated Incidence of Thyroid Cancer in the North East Region of Romania after 35 Years of Chernobyl Fallout. Is There a Link between?

Authors:  Laura Teodoriu; Maria Christina Ungureanu; Letitia Leustean; Cristina Preda; Delia Ciobanu; Irena Grierosu; Mioara Matei; Roxana Iacob; Cipriana Stefanescu
Journal:  Diagnostics (Basel)       Date:  2021-05-19

10.  Thyroid Dose Estimates for a Cohort of Belarusian Persons Exposed in Utero and During Early Life to Chernobyl Fallout.

Authors:  Vladimir Drozdovitch; Victor Minenko; Tatiana Kukhta; Sergey Trofimik; Rimma Grakovitch; Maureen Hatch; Elizabeth K Cahoon; Iliya Veyalkin; Olga Polyanskaya; Vasilina Yauseyenka; Evgenia Ostroumova; Kiyohiko Mabuchi; Alexander Rozhko
Journal:  Health Phys       Date:  2020-02       Impact factor: 2.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.